Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom

Julie C Evans, Timothy M Frayling, Paul G Cassell, Philip J Saker, Graham A Hitman, Mark Walker, Jonathan C Levy, Stephen O’Rahilly, Pamidighantam V Subba Rao, Amanda J Bennett, Elizabeth C Jones, Stephan Menzel, Philip Prestwich, Nikol Simecek, Marie Wishart, Ranjit Dhillon, Chris Fletcher, Ann Millward, Andrew Demaine, Terence Wilkin, Yukio Horikawa, Nancy J Cox, Graeme I Bell, Sian Ellard, Mark I McCarthy, Andrew T Hattersley

2001-09-01

Abstract:Variation in CAPN10, the gene encoding the ubiquitously expressed cysteine protease calpain-10, has been associated with type 2 diabetes in Mexican Americans and in two northern-European populations, from Finland and Germany. We have studied CAPN10 in white subjects of British/Irish ancestry, using both family-based and case-control studies. In 743 sib pairs, there was no evidence of linkage at the CAPN10 locus, which thereby excluded it as a diabetes-susceptibility gene, with an overall sib recurrence risk, λS, of 1.25. We examined four single-nucleotide polymorphisms (SNP-44, -43, -19, and -63) previously either associated with type 2 diabetes or implicated in transcriptional regulation of calpain-10 expression. We did not find any association between SNP-43, -19, and -63, either individually or as part of the previously described risk haplotypes. We did, however, observe significantly increased (P …